Sites of Insulin Injection (Lipoatrophy/Lipohypertrophy) | Changes in Subcutaneous Fat

Purpose: To evaluate a diabetic patient for changes in subcutaneous fat associated with insulin injections.

Info MyLikes MyPaths

Evaluation

Are you evaluating a skin lesion in a diabetic patient who injects insulin?

Yes

Gender of the patient

Male

Female

Is the patient concerned about the cosmetic appearance?

Yes

Select an appropriate answer for each finding

Appearance of skin lesion

Location of lesion relative to insulin injection site

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Features suggesting lipoatrophy

Features suggesting lipohypertrophy

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Clinical Diagnosis, Including Family History For Genetics
- Clinical Features of Allergic Flare Reaction to Intravenous Infusion of Drug
Severity, Prognosis, Stage
- Grading Severity of Infiltration and Extravasation Injury
Complications
- Techniques for Prevention of Extravasation Injury
- Continuous Insulin Infusion with Insulin Pump Risk Factors for Subcutaneous Abscess or Cellulitis

Therapy

Options
- Techniques for Prevention of Extravasation Injury
Administration
- Unsafe Injection Practices
- Site of Repeated Subcutaneous Injections | Cosmetic Skin Changes
Failure Handling And Therapy Escalation
- Unsafe Injection Practices
Prevention

Monitoring

Adverse Effects

Specialty

Toxicology
Emergency Medicine
Critical Care

Objective

administration
adverse effects
prevention

ICD-10

E88.1 - Lipodystrophy, not elsewhere classified

Info

Purpose: To evaluate a diabetic patient for changes in subcutaneous fat associated with insulin injections.

Specialty: Toxicology, Emergency Medicine, Critical Care

Objective: administration, adverse effects, prevention

ICD-10: E88.1,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path